TNH Insider Buys 2M Shares as Hospital Group Targets Record Revenue
This Aveluro analysis covers TNH (Tập đoàn Bệnh viện TNH) in the Thiết bị và Dịch vụ Y tế sector. The classified event type is insider trade, with positive sentiment and a deterministic market-impact score of 4.0/10. Aveluro classifies this story as a positive catalyst in the stock's news coverage. Source coverage came from CafeF - Thị trường chứng khoán, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Follow this event and trade Vietnam stocks
Use the broker guide to compare Vietnam market access before acting on this news.
Aveluro may earn a commission from broker partners. Market data and broker availability can change; confirm access before opening an account.
Overview
Nguyen Anh Dinh, Project Director of TNH Hospital Group (TNH, HOSE), purchased 2 million TNH shares between April 16 and May 15, 2026, increasing his stake from 3.7% to 4.91%. The transaction coincides with the company’s annual general meeting approving a 2026 business plan targeting record revenue of VND 836 billion but still expecting a net loss of over VND 51 billion.
Key Facts
- Nguyen Anh Dinh bought 2 million TNH shares from April 16 to May 15, 2026, via negotiated and/or order-matching methods.
- His stake rose from approximately 6.2 million shares (3.7%) to nearly 8.2 million shares (4.91%).
- Related parties (father Nguyen Van Thuy and brother-in-law Trieu Xuan Hung) hold a combined 12.18 million shares, or 7.35% of TNH.
- TNH’s 2026 AGM approved a revenue target of VND 836 billion, up 64% from 2025 and a record high.
- The company still expects a net loss of VND 51 billion in 2026, improving from a VND 93 billion loss in 2025.
- Interest expense is forecast to more than double to nearly VND 98 billion; depreciation and amortization to rise 31% to over VND 157 billion.
- Thai Nguyen International Hospital is expected to contribute VND 414 billion in revenue and VND 55 billion in after-tax profit; TNH Pho Yen Hospital revenue seen at VND 140 billion (+24%).
- TNH Viet Yen Hospital targets VND 135 billion in revenue (+120%) but is planned to lose over VND 62 billion due to high operating, personnel, and interest costs.
What Happened
Nguyen Anh Dinh, Project Director of TNH Hospital Group, reported the purchase of 2 million TNH shares to increase his ownership. The transaction was executed from April 16 to May 15, 2026, through negotiated and/or order-matching methods. After the purchase, his holdings rose from nearly 6.2 million shares (3.7%) to nearly 8.2 million shares (4.91%). Related parties, including his father Nguyen Van Thuy (3.93 million shares) and brother-in-law Trieu Xuan Hung (96,918 shares), collectively hold 12.18 million shares, representing 7.35% of the company.
Separately, TNH held its annual general meeting on May 15, 2026, approving a 2026 business plan with record revenue of VND 836 billion, a 64% increase from 2025. Despite the revenue growth, the company still expects a net loss of VND 51 billion, narrower than the VND 93 billion loss in 2025. The plan includes higher interest expense (nearly VND 98 billion, more than double) and depreciation (over VND 157 billion, up 31%). Among its hospitals, Thai Nguyen International Hospital is expected to be profitable with VND 55 billion after-tax profit on VND 414 billion revenue, while TNH Viet Yen Hospital is projected to lose over VND 62 billion despite a 120% revenue increase.
Market Context
TNH shares closed at VND 9,950 on May 18, 2026, down 0.30% with low volume of 77,300 shares. The stock trades on HOSE in the healthcare equipment and services sector. The insider purchase and record revenue target contrast with the company’s continued loss-making status, reflecting high expansion costs and debt servicing. TNH’s market capitalization remains modest, and the stock has been under pressure from ongoing losses and high financial leverage.
Strategic Significance
The insider purchase signals confidence from management in TNH’s long-term turnaround, particularly as the company targets record revenue driven by hospital expansions. The narrowing loss trajectory suggests that operational scale may eventually absorb fixed costs. However, the doubling of interest expense and high depreciation indicate that profitability remains dependent on achieving revenue targets and controlling costs at newer hospitals like Viet Yen. The related-party holdings concentration also highlights insider alignment with shareholder interests.
What to Watch
- Q2 2026 earnings release to assess revenue momentum and cost control progress.
- Updates on patient volumes and occupancy rates at Thai Nguyen International Hospital and Viet Yen Hospital.
- Any further insider transactions by the Dinh family or related parties.
- Changes in debt levels and interest expense trends in upcoming quarterly reports.
- Regulatory approvals or new hospital projects that could accelerate revenue growth.